发明名称 TRANSNASAL ANTICONVULSIVE PHARMACEUTICAL COMPOSITION
摘要 Disclosed herein is a transnasal anticonvulsive pharmaceutical composition comprising diazepam as an active ingredient, water, a fatty acid ester, diethylene glycol monoethyl ether, ethanol and sodium glycocholate, wherein the weight of the fatty acid ester is at least 2-fold higher than that of water and is at least 2-fold higher than that of ethanol. The anticonvulsive pharmaceutical composition for transmucosal delivery of diazepam according to the present invention includes a minimized content of water and ethanol, a fatty acid ester as a main ingredient and no use of a polar solvent, e.g. glycol, and exhibits improved diazepam solubility and transmucosal permeability due to using a small amount of water and ethanol. The present invention also includes treatment of convulsions by transnasally administering to a patient in need thereof a therapeutically effective amount of the disclosed compositions.
申请公布号 CA2678225(C) 申请公布日期 2014.10.21
申请号 CA20072678225 申请日期 2007.10.31
申请人 SK HOLDINGS CO., LTD. 发明人 KIM, KWON HO;KAUR, PARAMJEET;JO, JAE HOON;BAEK, MYOUNG KI;YUK, YEO JOO
分类号 A61K9/72;A61K31/5513;A61K47/10;A61K47/14;A61P21/02 主分类号 A61K9/72
代理机构 代理人
主权项
地址